Bioatla Number Of Shares Shorted vs. Cash Per Share
| BCAB Stock | USD 1.61 0.02 1.26% |
For Bioatla profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioatla to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioatla utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioatla's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioatla over time as well as its relative position and ranking within its peers.
Bioatla |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Revenue Per Share 0.228 | Quarterly Revenue Growth 0.316 | Return On Assets (0.50) | Return On Equity (1.39) |
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bioatla Cash Per Share vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bioatla's current stock value. Our valuation model uses many indicators to compare Bioatla value to that of its competitors to determine the firm's financial worth. Bioatla is rated below average in number of shares shorted category among its peers. It is rated below average in cash per share category among its peers . The ratio of Number Of Shares Shorted to Cash Per Share for Bioatla is about 867,693 . At present, Bioatla's Cash Per Share is projected to slightly grow based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioatla's earnings, one of the primary drivers of an investment's value.Bioatla Cash Per Share vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Bioatla |
| = | 4.14 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Bioatla |
| = | 4.77 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Bioatla Cash Per Share Comparison
Bioatla is currently under evaluation in cash per share category among its peers.
Bioatla Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bioatla, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bioatla will eventually generate negative long term returns. The profitability progress is the general direction of Bioatla's change in net profit over the period of time. It can combine multiple indicators of Bioatla, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 5.7 M | 6 M | |
| Interest Income | 5.7 M | 6 M | |
| Operating Income | -129.7 M | -123.2 M | |
| Net Loss | -124.1 M | -117.9 M | |
| Income Before Tax | -123.5 M | -117.3 M | |
| Total Other Income Expense Net | 6.2 M | 6.5 M | |
| Net Loss | -95.8 M | -91 M | |
| Net Loss | -123.5 M | -117.3 M | |
| Income Tax Expense | -1.1 M | -1 M | |
| Non Operating Income Net Other | 1.5 M | 1.3 M | |
| Change To Netincome | 16.8 M | 17.6 M | |
| Net Loss | (2.58) | (2.71) | |
| Income Quality | 0.84 | 0.90 | |
| Net Income Per E B T | 1.14 | 1.12 |
Bioatla Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bioatla. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioatla position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioatla's important profitability drivers and their relationship over time.
Use Bioatla in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioatla position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will appreciate offsetting losses from the drop in the long position's value.Bioatla Pair Trading
Bioatla Pair Trading Analysis
The ability to find closely correlated positions to Bioatla could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioatla when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioatla - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioatla to buy it.
The correlation of Bioatla is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioatla moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioatla moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioatla can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bioatla position
In addition to having Bioatla in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
To fully project Bioatla's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioatla at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioatla's income statement, its balance sheet, and the statement of cash flows.